Dr. Klein on “taking the extra step” when caring for transgender and gender-diverse patients
“From a clinician’s perspective…these medications and these diagnoses happen when there’s not enough care from the start,” says David A. Klein, MD, MPH.
In this video, David A. Klein, MD, MPH, advises practitioners on how to manage transgender and gender-diverse patients beyond gender-affirming medications and basic referrals. Klein is an associate professor of family medicine and pediatrics at Uniformed Services University, Bethesda, Maryland.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
